Clinical Trials Browser

High-Throughput Screening Assays × Other hematologic neoplasm × 90 days × Clear all

NCT03389347 2026-05-08

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Phase NA Active not recruiting

40 enrolled 7 charts

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma